- Poster presentation
- Open Access
Gender specific differences in left ventricular remodelling in obesity may explain differences in obesity related mortality
© Rider et al; licensee BioMed Central Ltd. 2012
- Published: 1 February 2012
- Cardiovascular Magnetic Resonance
- Left Ventricular Mass
- Left Ventricular Remodel
- Traditional Cardiovascular Risk Factor
- Body Mass Index Level
Across both genders, obesity, in the absence of traditional cardiovascular risk factors, is characterized by concentric LV remodeling. Whereas males show predominantly concentric remodeling, females exhibit eccentric and concentric hypertrophy. This may explain the observed gender difference in obesity related cardiovascular mortality.
Obesity related cardiovascular mortality, although elevated when compared to normal weight, is lower in females (♀) than males (♂) at every body mass index (BMI) level. Given the fact that males have less fat tissue than females at each BMI level, the reasons behind this trend are unlikely to be attributable to the effects of excess adiposity alone.
As different patterns of left ventricular (LV) remodeling have been shown to have varying prognostic value, with concentric hypertrophy being more strongly predictive of cardiovascular mortality than eccentric hypertrophy, our aim was to investigate whether sex-specific differences in LV remodeling could provide an additional explanation for the observed gender difference in obesity related mortality.
703 subjects (♀ n= 390, ♂ n=313) without identifiable cardiovascular risk factors, (BMI range 15.7-59.2 Kg/M2) underwent cardiovascular magnetic resonance at 1.5 Tesla for the assessment of LV mass (g), end-diastolic volume (EDV; ml) and LV mass/volume ratio (LVM/VR).
Across both genders, obesity, in the absence of traditional cardiovascular risk factors, is characterized by concentric LV hypertrophy. Whereas males show predominantly concentric remodeling, females also exhibit a degree of cavity dilatation suggesting that a mixed pattern of eccentric and concentric hypertrophy is present. Given the fact that concentric hypertrophy is a more powerful predictor of cardiovascular risk, this may go some way to explain the observed gender difference in obesity related cardiovascular mortality.
The study was supported by a grant from the Wellcome Trust and by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. SN acknowledges support from the Oxford BHF Centre of Research Excellence.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.